Susquehanna International Group, LLP Atri Cure, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 65,488 shares of ATRC stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,488

Previous 23,128 183.15%

Holding current value

$2.06 Million

Previous $706,000 199.15%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$30.4 - $42.4 $1.29 Million - $1.8 Million	42,360 Added 183.15%	65,488 $2.11 Million
Q4 2024 Feb 14, 2025	BUY	$27.02 - $38.2 $290,302 - $410,420	10,744 Added 86.76%	23,128 $706,000
Q3 2024 Nov 14, 2024	BUY	$20.34 - $29.5 $251,890 - $365,328	12,384 New	12,384 $347,000
Q1 2024 May 07, 2024	BUY	$28.21 - $37.78 $886,329 - $1.19 Million	31,419 Added 69.64%	76,533 $2.33 Million
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $1.12 Million - $1.47 Million	33,973 Added 304.94%	45,114 $1.61 Million
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $1.18 Million - $1.66 Million	-28,698 Reduced 72.03%	11,141 $487,000
Q2 2023 Aug 11, 2023	BUY	$40.44 - $49.6 $777,620 - $953,758	19,229 Added 93.3%	39,839 $1.97 Million
Q1 2023 May 16, 2023	BUY	$35.87 - $47.22 $352,064 - $463,464	9,815 Added 90.92%	20,610 $854,000
Q4 2022 Feb 14, 2023	SELL	$33.48 - $47.45 $92,706 - $131,389	-2,769 Reduced 20.41%	10,795 $479,000
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $518,823 - $713,737	13,564 New	13,564 $530,000
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $265,843 - $330,464	-4,629 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$63.4 - $87.14 $226,338 - $311,089	-3,570 Reduced 43.54%	4,629 $322,000
Q2 2021 Aug 11, 2021	BUY	$64.13 - $80.18 $278,131 - $347,740	4,337 Added 112.3%	8,199 $650,000
Q1 2021 May 17, 2021	SELL	$53.79 - $66.98 $316,500 - $394,110	-5,884 Reduced 60.37%	3,862 $253,000
Q4 2020 Feb 16, 2021	BUY	$34.56 - $57.55 $156,453 - $260,528	4,527 Added 86.74%	9,746 $543,000
Q3 2020 Nov 16, 2020	SELL	$38.36 - $46.91 $2.67 Million - $3.26 Million	-69,553 Reduced 93.02%	5,219 $208,000
Q1 2020 May 15, 2020	BUY	$24.49 - $43.84 $1.25 Million - $2.25 Million	51,225 Added 217.54%	74,772 $2.51 Million
Q3 2019 Nov 14, 2019	BUY	$23.81 - $32.52 $226,480 - $309,330	9,512 Added 67.77%	23,547 $587,000
Q2 2019 Aug 16, 2019	BUY	$26.85 - $30.74 $119,428 - $136,731	4,448 Added 46.4%	14,035 $419,000
Q2 2019 Aug 14, 2019	SELL	$26.85 - $30.74 $840,082 - $961,793	-31,288 Reduced 76.55%	9,587 $286,000
Q1 2019 May 15, 2019	BUY	$26.38 - $33.34 $1.08 Million - $1.36 Million	40,875 New	40,875 $1.1 Million

Others Institutions Holding ATRC

# of Institutions

238

Shares Held

52M

Call Options Held

32.6K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.46B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Atri Cure, Inc. Transaction History